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Abstract
Odontogenic keratocysts (OKCs) are developmental cysts of the jaws that require proper diagnosis due to their potential for local
aggressive growth and recurrences. OKCs have a typical parakeratotic epithelium demonstrating transepithelial cytokeratin 17
(CK17) and basal bcl2 staining on immunohistochemistry (IHC), which distinguishes them from other common jaw cysts.
Secondary to inflammation, the epithelial lining may be altered and loses the typical IHC phenotype. The aim of the present study
was to analyse a series of consecutive jaw cysts for their expression of CK17 and bcl2 and assess how these IHC stains may help in
their diagnosis. All cysts were retrospectively assessed for available clinical, radiological and pathological findings and diagnoses
were revised whenever needed. 85 cysts from 72 patients were collected from two departments. The series had 21 OKCs, the
remaining non-OKCs included radicular/residual, dentigerous, paradental, lateral periodontal, botryoid odontogenic cysts. OKCs
with typical epithelium showed the typical IHC phenotype, which was generally lost in inflammation-associated altered epithelium.
Contrarily to earlier descriptions, a wide variety of CK17 positivity was seen in the majority of non-OKCs, including focal
transepithelial staining. Basal bcl2 staining was also seen in 16 non-OKCs. These stainings were never as strong in intensity as
seen in OKCs. One case was histopathologically identified as OKC due to focally maintained IHC profile. CK17 and bcl2 IHCmay
help in the diagnosis of OKCs, but must be interpreted with caution and is not a yes or no tool in the diagnostic puzzle.
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Introduction
Cystic or cyst-like lesions of odontogenic origin include in-
flammatory, developmental and neoplastic lesions [1]. They
may lead to the loosening of the teeth, predisposition to frac-
ture of the involved bone, inflammatory consequences, pain,
swelling or other symptoms. The lesions are sometimes very
difficult to differentiate from each other. For example, an api-
cal granuloma and a radicular cyst cannot be distinguished on
clinical grounds alone unless the dynamism of development is
available; the verification of epithelial lining requires a histo-
logical sampling, most often the removal and histological ex-
amination of the lesion [2]. Some of the cysts are less noxious
than others. Most have characteristic clinical / radiological
findings, but these are often overlapping. Ameloblastoma,
the most common odontogenic tumour is also characteristical-
ly cystic, and unicystic ameloblastoma shows an overlap in
localisation, age group and radiological findings with
odontogenic keratocysts (OKC) [1].
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OKCs are presently classified as tumour-like cystic lesions,
but in the previous edition of the WHO classification, they
were among the tumours, as keratocystic odontogenic tu-
mours, on the basis of the common mutation identified in
the Patched-1 gene of the sonic hedgehog pathway, a key
event in the development of the nevoid basal cell carcinoma
syndrome, the Gorlin-Goltz syndrome [3, 4]. They are pro-
gressively growing, locally aggressive lesions prone to recur-
rence unless completely excised. Recurrences may occur from
daughter cysts, invaginations or nests of odontogenic epithe-
lium. These clinical features make the recognition, proper di-
agnosis and treatment of OKCs important.
OKCs have a predilection site at the posterior mandible, in
the angle and ramus of the bone and an association with third
molars, but may occur anywhere in the jaws. They are often
discovered incidentally as radiolucencies of regular, often
scalloped outlines with a common corticated edge; often the
size is considerable at the time of diagnosis [1, 5]. The age
distribution peaks in the 2nd and 3rd decade, with a smaller
peak around the 6th decade, but the lesion may be seen in a
wide age range. Males are about two times more commonly
affected than females. These features may lead to the clinical
diagnosis or suspicion of OKC, but are not distinctive enough.
OKCs have a characteristic and therefore diagnostic epithelial
lining consisting of a relatively thin (a few, 5–8 cells thick)
parakeratotic squamous epithelium typically showing at least
partial waviness of the surface. The basal cells are arranged in
a palisading pattern, may show a reverted polarity with the nu-
cleus located in the upper half of the cell rather than basally, and
the boundary of the supportive connective tissue and the epithe-
lium is generally smooth and even. This histology permits the
diagnosis of OKCs, and helps to distinguish them from
orthokeratotic odontogenic cysts (which were separated from
OKCs in the latest edition of the WHO classification of head
and neck tumours [1, 6]) and other odontogenic cysts [1]. The
epithelial lining of OKCs has also a characteristic staining profile
on immunohistochemistry (IHC), which includes transepithelial
staining with cytokeratin 17 (CK17) and to a lesser degree
CK19, superficial staining with CK10 and basal/suprabasal
staining with bcl2 [7–10]. This also distinguishes them from
other common cystic lesions of the jaws (Fig. 1) [7, 8].
It has been recognized earlier, that this staining patternmay be
disturbed at sites of inflammation [7], and inflamed cysts show a
non-specific epithelial lining. Indeed, epithelial changes seen in
connection with secondary inflammation due to fistular connec-
tions, previous biopsy or cyst reduction procedures have been
associated with complete or partial loss of the diagnostic epithe-
lium and its immunostaining profile [9]. This partial or potential-
ly complete loss of the typical epithelium, just as the lack of
adequate and relevant clinico-radiological features may lead to
misdiagnosis ofOKCs as inflammatory cysts. Our previouswork
has suggested that with the epithelial changes in place, some
areas may still show the IHC profile of OKCs, and this
phenomenon could support the diagnosis or be consistent with
the diagnosis in some difficult cases, especially on biopsy [9].
In the present work we sought at analysing consecutive jaw
cysts with residual epithelium to look for the potential value of
CK17 and bcl2 IHC (the two most consistent and
distinguishing IHC reactions available, Fig. 1) in the proper
diagnosis of these cysts and see how these stains (along with
clinical and radiological data) are helpful in the differential
diagnosis, especially the diagnosis of OKCs.
Materials and Methods
Materials from patients consecutively operated on for jaw
cysts and received at the Departments of Pathology of either
the Bács-Kiskun County Teaching Hospital of the University
of Szeged (Site A) or the Albert Szent-Györgyi Medical
Centre of the University of Szeged (Site B) were used for
analysis. Clinical and radiological data were retrieved from
the patients’ digital medical charts.
IHC was performed on 3–4-μm-thick sections from forma-
lin fixed and paraffin embedded blocks with the following
antibodies: (Site A:) bcl2: Novocastra/Leica (Newcastle,
UK), clone E3.1 (dilution 1:80); CK17 Novocastra/Leica
(Newcastle, UK), clone E3 (ready-to-use, dilution 1:2); occa-
sionally CK10 MasterDiagnostica (Granada, Spain), clone
SP99 (ready-to-use); and CK19 CellMarque (Rocklin,
California, USA), clone A53B/A2.26 (dilution 1:500); (Site
B:) bcl2: Labvision/NeoMarkers (Fremont, CA, USA), clone
124 (dilution 1:300); CK17 Labvision/NeoMarkers (Fremont,
CA, USA), clone E3 (dilution 1:40). At site A, a 45-min-water
bath (98 °C, pH 6, citrate buffer; for bcl2 and CK19) or a high-
pressure (pH 9, TRIS-EGTA buffer; for CK10) heat induced
epitope retrieval was used prior to the 60-min-incubation at
room temperature, and the reactions were developed with
Vector ImmPRESS (Vector Laboratories, Burlingame, CA,
USA; 30 min, room temperature) using Novared as chromo-
gen; The CK17 reaction used epitope retrieval with ER1 so-
lution (20 min), incubation time on the Bond Max autostainer
(Leica Biosystems, Wetzlar, Germany) was 15 min. At site B,
bcl2 and CK17 IHC were run on a Bond Max autostainer
(Leica Biosystems, Wetzlar, Germany) with epitope retrieval
with ER2 (pH 9) solution for 20 min and incubation time of
20 min. (CK10 and CK19 were only occasionally obtained,
and results are presented only in the supplementary material.)
While interpreting the bcl2 IHC reactions, obvious, strong
staining patterns were appreciated, whereas diffuse weak
background-like staining was ignored, and intralesional lym-
phocytes served as a control for the staining, both for its pres-
ence and its intensity (see supplementary material).
As the clinical diagnoses were sometimes non-specific
(e.g. maxillary cyst or odontogenic cyst?), relevant clinical
data were occasionally missing from the pathology request
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forms, and the pathology reports commonly neglected the
(missing) clinical data, the clinical, radiological and histopath-
ological findings were revised in all cases, as much as possi-
ble, and a final, clinicopathological diagnosis was established.
The clinical data, imaging (where available), histology and
diagnoses are shown on a case by case basis in the supple-
mentary material.
The study was approved by the Ethical Committee of the
University of Szeged.
Results
Altogether 50 cysts were collected from 45 patients at site A,
and 35 cysts from 27 patients at site B. The 85 cysts analysed
were removed from 45 male and 27 female patients. Their
median age was 44 years (range: 11–76).
The histology request forms at site A were often more
informative with helpful clinical information communicated
and diagnoses suggested, whereas those of site B were gener-
ally less helpful, and often included the questioned diagnosis
of OKC even if this was not well founded clinically (radiolog-
ically). On the basis of the clinical diagnoses suggested on the
histopathology request forms at site A, there were 20 cysts not
otherwise specified (NOS) or with at most the bone and/or the
teeth places specified; 19 radicular, residual or periapical
cysts; 4 dentigerous (follicular) cysts; 2 OKCs; 1
“globulomaxillary” cyst; and 3 cysts with a differential diag-
nosis of two entities (2 OKC vs follicular cyst and 1 radicular
vs “globulomaxillary” cyst). An OKC was sent in as inflamed
maxillary sinus mucosa (case K1), although the diagnosis of a
dentigerous cyst was mentioned in previous medical records
not cited on the request form. The request forms at site B
suggested 4 cysts NOS (with or without a communicated lo-
cation; 1 with the possibility of ameloblastoma questioned), 3
radicular cysts, and the remaining 28 forms all raised the
question whether the cyst represented an OKC or not.
Altogether, the final revised clinicopathological diagnosis
was (or was consistent with) OKC in 21 cysts from 13 patients
(24.7%;) of which 16 cysts had this diagnosis mentioned on
the histology request form. These cases included two recurrent
OKCs (with only one mentioning the previous operation on
the request form) and 12 cysts from 4 patients associated with
the Gorlin-Goltz syndrome. Further 3, 1 and 1 cases were
submitted as residual, dentigerous or NOS cysts, respectively,
the latter also raising the possibility of an ameloblastoma.
Nineteen of these OKCs had typical histological findings in-
cluding a thin parakeratotic epithelium with wavy surface and
basal palisading of nuclei, commonly with an even epithelial
stromal interface. They also showed a diffuse and strong
transepithelial CK17 and basal/suprabasal bcl2 staining. One
syndromic case also demonstrated areas with superficial layer
negativity, but had other areas of well-developed
transepithelial staining. A further case (K2) showed thickened
non-keratinizing squamous epithelium, with a tiny focus of
desquamated epithelium with basal palisading and marked
basal bcl2 staining and patchy (non-OKC-like) transepithelial
CK17 staining. In addition, CK10 staining was also available
and demonstrated a superficial focal staining. Other areas of
the non-OKC-like epithelium demonstrated transepithelial
CK19 positivity. These IHC results were at least partially in
keeping with the typical patterns seen in OKCs, and the radi-
ology and clinical features were also consistent with this di-
agnosis, despite the original clinical diagnosis of a residual
cyst (Figure 2). On revision of the case and recut slides, a tiny
part of more typical OKC epitheliumwas also discovered, this
demonstrated the typical transepithelial CK17 and basal bcl2
staining (Fig. 2 M, N, O). One further cyst (K19) demonstrat-
ed a non-specific thickened squamous epithelial lining in a
background of heavy inflammatory infiltrate. None of the 6
blocks taken from this cyst of 43 mm in greatest dimension
demonstrated the histological or IHC features of an OKC.
However, on clinical and radiological grounds (dimensions,
mesiodistal growth without buccolingual extension), the cyst
was interpreted as best fitting the diagnosis of and inflamed
Fig. 1 Differential immunoprofile of common odontogenic cysts based
on profiling studies and personal experience [7–10]. (CK: cytokeratin,
OKC: odontogenic keratocyst, OOC: orthokeratotic odontogenic cyst,
RC: radicular cyst, DC: dentigerous (follicular) cyst; na: not available).
White numbers in the figure refer to the proportion of cases stained. Data
adopted and derived from results and figures of the referenced
publications. Differences in staining intensity and diffuse versus patchy
staining could not be considered in the figure, except for *: all cases
showed focal superficial and upper spinous CK10 staining, with areas
of epithelium fully devoid of staining, and this could be interpreted as
negative or positive, depending on the vantage point
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OKC with modified epithelium, in keeping with the original
clinical diagnosis (Figure 3).
From the clinical side, 31 cases had the diagnosis of
OKC mentioned on the histology request form either as a
clinical diagnosis or as part of clinical differential diagno-
ses or reflecting the surgeon’s fear of missing an OKC
and asking on OKC just as on possible signs of malignan-
cy. Sixteen of these proved to be OKCs, whereas 5 were
finally diagnosed as dentigerous cysts or were consistent
with this diagnosis (K3, KR10, S3, S17, S21), 7 were
classified as radicular/residual cysts (S7, S18, S19, S32,
S34, S37, S39), and finally 4 cases (S6, S8, S27, S41) had
a diagnosis of odontogenic cyst NOS. None of the latter
demonstrated the HE features of OKCs, or a strong
transepithelial CK17 and basal/suprabasal bcl2 positivity.
However, weak focal superficial to marked superficial to
focal transepithelial CK17 staining was identified in their
majority (see below).
When taking into consideration the 64 cysts with a non-
OKC final clinicopathological diagnosis, a generally focal su-
perficial CK17 staining with a few cells of the luminal layer
nearly unnoticeably labelled to definite superficial cell posi-
tivity was very commonly seen (n = 16), and this was either
associated with focal transepithelial staining or focal
transepithelial staining occurred without such superficial
staining in many (n = 24) further cases. Additionally, some
cases (n = 10) showed basal or upper to middle spinous layer
cells labelled focally (Figure 4). Only 14 cases showed no
CK17 positivity at all in the investigated tissue block. Bcl2
was generally interpreted as negative in these cysts, but the
basal cell layer was stained either focally or diffusely in 16
cases, and these included 8 dentigerous cysts (K15, KR3,
KR7, KR11, S3, S17, S21, S27), 1 botryoid odontogenic cyst
(K9) 1 nasopalatine duct cyst (S38), 1 inflamed lateral peri-
odontal cyst (K7), 4 residual/radicular cysts (K6, S20, S34,
S37) and 1 odontogenic cyst NOS (S8) (Figure 4). Focal
Fig. 2 Inflamed OKC with minimal residual typical epithelium. A-C:
orthopantomogram, and details of a sagittal and coronal plane image
from the computed tomography scan of the cyst highlighted by arrows
(case K2); note the large corticated radiolucent area in the angle and
ramus of the mandible growing “within the bone” without conspicuous
lingual / buccal extension. D-F: low power views of one section
highlighting the heavy inflammatory infiltrate; H-I: medium power
views of the non-specific squamous epithelium demonstrating focally
transepithelial (arrowheads) CK17 staining (H) without bcl2 labelling
of the epithelium (I); J-L: high power view of the tiny non-typical
(probably transitional) epithelial fragment pointing to the possible OKC
origin of the inflamed cyst with strong basal bcl2 labelling (arrows) (L)
and non-typical patchy basal-spinous-superficial, i.e. “transepithelial”
CK17 staining (K); M-O: the 1.1-mm-long typical epithelial fragment
identified on revision and recut also demonstrating the typical strong
transepithelial CK17 (N) and basal bcl2 (O) stainings. (D,E,F: ×1; G,
H, I: ×12; J, K, L: ×25; M, N, O: ×35; D, G, J, M: haematoxylin and
eosin; E, H, K, N: CK17; F, I, L, O: bcl2)
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weak/moderate intensity spinous cell or transepithelial label-
ling was seen in 5 cases with non-OKC histology.
Overall, 7 non-OKC cases (K7, K9, K15, KR7, KR11,
S27, S37) had both a focal transepithelial CK17 and a basal
bcl2 staining. Of these, a botryoid odontogenic cyst (K9) had
distinctive histology (Fig. 4 C, D); the remaining included 4
dentigerous cysts, a mature radicular cyst (S37), and an in-
flamed lateral periodontal cyst (K7). None of the IHC
stainings overlapping with the transepithelial CK17 and bas-
al/(suprabasal) bcl2 positivity of the OKC had patterns
(stainings occurring at the same site) and intensity to be mixed
up with that seen in OKCs.
In contrast, 12 OKCs with inflammation and areas of modi-
fied epithelium associated with it, showed a staining typical of
non-OKCs in these areas, in keeping with the altered epithelial
lining of the cysts. Lack of the marked basal bcl2 staining and
negativity or variable superficial or focal, weaker, patchy
transepithelial CK17 staining were the characteristic patterns
seen in these areas (Fig. 3) with no combination of strong
transepithelial CK17 and basal bcl2 positivity. To note, bcl2
staining of control lymphocytes was weak after decalcification
of case K19 compared to the biopsy sample of the same cyst and
samples of other cysts (Fig. 3, Supplementary material).
Discussion
Of the odontogenic cysts, OKC is one of the most challenging
ones. It is sufficiently common, has a relatively high rate of
recurrence if not completely removed, and can have out-
growths, daughter cysts making it difficult to be removed in
toto. Although OKCs have clinical and radiological features
allowing for a clinical suspicion or diagnosis, there are other
lesions with overlapping qualities, therefore a histological
confirmation of the diagnosis is always required. On the other
hand, although OKCs have a typical histological appearance
(Fig. 2 M, N, O), these characteristics may be completely or
largely lost in association with secondary inflammation. This
Fig. 3 Inflamed OKC without
residual typical epithelium. A-D:
orthopantomogram, and details of
a coronal, axial and sagittal plane
images from the computed
tomography scan of the cyst
highlighted by arrows (case K19);
note the large corticated
radiolucent area with scalloped
borders growing “within the
bone” without conspicuous
lingual or labial/buccal extension.
E: Non-specific focal superficial
CK17 labelling of the lining
epithelium (CK17, ×5); F: The
epithelium is bcl2-negative in the
previous biopsy sample with
strong lymphocyte staining as
internal control (bcl2, ×20);
which is much weaker in the
decalcified resection specimen
(H, bcl2, ×18); G: Overview of
the inflamed cyst wall with
fragments of bone on the top part
of the image (haematoxylin and
eosin, ×1.4)
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is why combination of clinical, radiological and pathological
findings are optimally needed for the proper diagnosis of the
lesions. This combination of data was missing in a number of
cases for the original reports, and was compensated for by the
clinical, radiological and pathological review of all available
data from the patients’ charts. This review of each individual
case is a special strength of this study.
The distinctive CK17 and bcl2 IHC of OKCs consists of a
strong transepithelial CK17 positivity (with or without focal bas-
al or superficial sparing) and a strong basal (with or without
weaker suprabasal) bcl2 positivity (Fig. 1, Fig. 2 M, N, O)
[7–9]. Meara et al. have suggested that a strong CK17 positivity
in all layers may point to syndromic OKCs, although they noted
similar staining in 2/7 of their sporadic OKC cases as well; they
also reported focal or only basal or only superficial CK17 label-
ling in 4/7 non-syndromic OKCs [11]. In keeping with these
results, syndromic OKCs generally had strong CK17 staining,
but sporadic cases also displayed similar intensities; in contrast,
some areas displayed superficial sparing with CK17 in two
OKCs fromGorlin-Goltz syndrome patients. Focal basal sparing
was also seen in a few OKCs of this series, but all 20 cases
studied with typical epithelium had marked transepithelially
stained areas.
Secondary to inflammation, an altered epitheliummay replace
the typical lining of OKCs, and this is characterized by the loss of
the typical IHC staining profile as well, although focal (transition-
al or typical) areas with typical IHC staining may remain and can
be helpful in the diagnosis [9]. Twenty of the 21 OKCs of this
consecutive series had the typical epithelium and IHC profile at
least focally, whereas in one case, the epithelium was completely
replaced by a non-specific squamous one lacking the typical IHC
staining of OKCs; its diagnosis was established as being most
consistent with an inflamed OKC on the basis of clinical and
radiological data (Fig. 3). Marsupialization also leads to second-
ary inflammation, and loss of the typical basal bcl2 staining was
interpreted as a sign of treatment effect in OKCs [12].
In contrast to the results of the detailed cytokeratin profiling
studies by Aragaki [7] and Tsuji [8] comparing other common
odontogenic cysts with OKCs (Fig. 1), many, though not all
radicular and dentigerous cysts were not completely negative
for CK17, but demonstrated some kind of staining (superficial
layer, spinous layer, basal or even focal transepithelial labelling).
Fig. 4 Examples of non-OKCs
with CK17 and / or bcl2
positivity. A-B: Mature radicular
cyst (Case K5) with various
patterns of CK17 positivity (A)
including basal (arrows),
superficial (arrowheads),
transepithelial (inset) staining and
negativity (*) and no bcl2 staining
(B). C-D: Botryoid odontogenic
cyst (Case K9) with partial
superficial CK17 positivity (C)
and basal bcl2 positivity (D). E-F:
Dentigerous cyst (Case K15) with




staining and negativity (+),
associated with bcl2 negativity
(F). Bcl2 was basally positive
elsewhere. G-H: dentigerous cyst
(Case S21) with superficial CK17
(G) and basal bcl2 (H) stainings
(A-B: ×5, C: ×20, D: ×40, E-F:
×10, G-H: ×20; A, C, E, G:
CK17; B, D, F, H: bcl2)
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This was never very strong, but small biopsies obtained during
cystostomies may yield a confounding piece of epithelium with
OKC-mimicking transepithelial CK17 staining. Others have also
reported at least focal CK17 labelling in (some) dentigerous
cysts, including the superficial layer staining often observed in
the present study [11, 13–15]. Although a study by Zivkovic and
colleagues looking at 30 dentigerous cysts reported
transepithelial staining in these, using the same E3 clone CK17
antibody as in the present study (although from another manu-
facturer) [16], their results are in contradiction with our and
others’ findings [7, 8, 11, 13–15]. In contrast to previous reports
on the lack of expression of CK17 in radicular cysts [8, 16], the
present study also found at least focal CK17 positivity in 25/34
radicular cysts. In concordance with the present results, non-
transepithelial CK17 staining of the epithelium of some radicular
cysts weaker than in OKCs was reported by Stoll et al. [13].
Basal bcl2 labelling was not common in non-OKCs, but was
also seen in some other cyst types, most commonly in
dentigerous cysts. Several studies have examined the bcl2 stain-
ing ofOKCs versus other cysts, with the aim of substantiating the
neoplastic nature of the former. For example, Piattelli et al. found
bcl2 positivity (defined as >10% staining) in only 1/20
dentigerous cysts, and their 20 radicular cysts were all negative,
in contrast to the 20 OKCs studied and unanimously showing
basal bcl2 labelling. The authors not only proposed that bcl2
could play a role in the aggressive growth of OKCs, but believed
that this was also useful as a diagnostic tool [17]. Similar results
were reported by others, and finally a recent systematic review
concluded that bcl2 positivity was somuch greater in OKCs than
dentigerous cysts, that it should be partly responsible for the
active growth of OKCs through the inhibition of apoptosis, and
therefore be a phenomenon in support of the neoplastic nature of
OKCs [10]. However, the systematic review included only 36
dentigerous cysts and 4 of these (11%) showed bcl2 positivity
[10]. Our study concentrated more on diagnostic uses of staining
patterns rather than quantifying the cells stained. As a conse-
quence, we were interested in any staining pattern that could
mimic the typical basal positivity ofOKCs, even if this was focal.
In fact, bcl2 positivity was never as strong and diffuse in other
cyst types, but there were some cysts that clearly exhibited con-
tinuous basal layer bcl2 labelling of weak to moderate intensity;
these were predominantly developmental cysts, mostly
dentigerous cysts (8/16 non-OKCs with basal bcl2 labelling),
but radicular cysts (especially mature ones with atrophic epithe-
lium) were also identified as having this staining pattern. Our
findings are reinforced by the findings of Martins et al., who also
found some basal bcl2 expression in non-inflamed radicular cysts
although this was less common than that seen in similarly atro-
phic dentigerous cysts [18]. These authors also proposed that
inflammation may inhibit bcl2 expression and therefore contrib-
ute to similarities of inflamed cysts of radicular and dentigerous
origin. This suggestion may probably be generalized to most
inflamed cysts with non-specific squamous epithelium.
The association of a strong basal bcl2 and significant
transepithelial CK17 stainings in the same areas of non-OKC
was not encountered in this series, but cannot be completely
excluded on the basis of the number of cases studied.
The consecutive series (on the basis of the clinicopathological
diagnoses), as could be expected, contained mainly the
commonest odontogenic cysts, i.e. radicular cysts, dentigerous
cysts and OKCs. The latter were slightly overrepresented be-
cause of surgeries on 4 patients with the Gorlin-Goltz syndrome
and up to 5 OKCs removed from these patients. However, the
series also included a few rarer cysts like a paradental cyst (in-
flammatory collateral cyst) (K17), one botryoid odontogenic cyst
(K9), one nasopalatine duct cyst (S38) and lateral periodontal
cysts (K7, K16, K22). Of these, the developmental cysts without
inflammation demonstrated some (faint to moderate) basal bcl2
staining, without suprabasal extension, and all of the rarer cyst
types also displayed various CK17 expression, including focal
transepithelial staining (Fig. 4, Supplementary material). None of
these created differential diagnostic problems regarding OKC. In
fact, the basal bcl2 seen in some dentigerous and botryoid cysts
suggests that this pattern may be more common in developmen-
tal cysts. A strong bcl2 expression was also described in a
botryoid odontogenic cyst reported recently, being the only case
studied in this respect we could identify [19].
To summarize, the study strengthens that the strong diffuse
transepithelial CK17 and basal bcl2 are typical of OKCs, but also
highlights that these patterns of staining, although to a lesser
intensity and extent, can be seen in other odontogenic cysts,
too. This is in contradiction with some previous publications
referring to the CK17 negativity of radicular and dentigerous
cysts [7, 8]. Although the characteristic CK17 and bcl2 IHCs
are rare in combination in non-OKCs, inflamedOKCs also loose
these stains at the sites of altered epithelium, whichmay form the
majority or the whole of the cyst lining. Therefore, these IHC
patterns cannot serve as a yes or no alternative of the clinicopath-
ological diagnostic steps of OKCs, but are rather adjuncts that
can serve in some difficult cases. The present experience sug-
gests that they have limited value in the differential diagnosis.
The only cyst (K2) where the IHC helped to make the diagnosis
of OKC was an inflamed OKC with a small bit of transitional
epithelium with basal bcl2 and patchy transepithelial (non-
typical) CK17 staining and minimal typical residual epithelium
identified only on revision and recut.
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